483 Taejoon Pharm Sep 2018

483 Taejoon Pharm Sep 2018

$119 - Not in Stock

FDA investigators audited the Taejoon Pharm - Yongin, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 18 Sep 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Sep 2018
  • Location: Yongin, Korea (the Republic of)
  • FEI: 3008029795

Pre-Order Not Available